One of the key areas of interest for development of products in surgical sealing, closure and hemostasis is in neural tissue surgery, encompassing chronic stroke, spinal cord trauma, neurovascular defects, and brain tumor treatments. In the U.S. alone, there were some 5.6 million patients in this category in 2008 who could benefit from these products.
The neural application with the biggest potential is in the treatment of epilepsy. Surgical intervention is currently used in many of these intractable cases to remove or disconnect selected areas of the brain. New products for sealing, hemostasis and closure offer potential to augment surgical procedures to rectify these regions of brain activity, and a number of new developments have targeted this clinical area.
Potential for Neurological Applications, Prevalence of Applicable Disorders
Source: MedMarket Diligence Report #S175, "Worldwide Market for Surgical Sealants, Glues and Wound Closure, 2009-2013."
The potential for new sealant, hemostasis and closure treatments in neurology stems from the need to facilitate existing surgical treatments of neural disorders; most existing alternative treatments are pharmological therapies limited to reducing symptoms, since few cures exist.
An important driver in this market segment is the increasing aging population, with a consequent growing prevalence of age-related disorders. Also, new improved systems for diagnosis promise the possibility of earlier intervention.